Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. |
First Approval Date07 Apr 2014 |
|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. |
First Approval Date24 Jan 2003 |
|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date30 Apr 1996 |
100 Clinical Results associated with Eurocept International B.V.
0 Patents (Medical) associated with Eurocept International B.V.
100 Deals associated with Eurocept International B.V.
100 Translational Medicine associated with Eurocept International B.V.